Tumor inhibition was associated with decreased proliferation (i.e., Ki-67) and increased apoptosis (i.e., cleaved Caspase 3) indicative of the anti-tumor effects of the treatments (Supplementary Fig. 10b). This evidence concerns the gene CASP3 and neoplasm.